NAS:IDXX (USA) Also trade in: Austria Germany UK

IDEXX Laboratories Inc

$ 284.69 -5.16 (-1.78%)
Volume: 384,135 Avg Vol (1m): 362,301
Market Cap $: 24.49 Bil Enterprise Value $: 25.42 Bil
P/E (TTM): 64.26 P/B: 483.36
Earnings Power Value 29.04
Net Current Asset Value -10.64
Tangible Book -2.31
Projected FCF 37.97
Median P/S Value 108.62
Graham Number 0
Peter Lynch Value 82.13
DCF (FCF Based) 76.03
DCF (Earnings Based) 88.29
1Y (-%)

IDXX News and Headlines - IDEXX Laboratories

GuruFocus Articles Total 104
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

PR Newswire

WESTBROOK, Maine, July 18, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced today the election of Sam Samad, the Senior Vice President and Chief Financial Officer of Illumina, Inc., as a member of the Company's Board of Directors, effective July 16, 2019.

"We are very pleased to welcome Sam to our Board of Directors," said

0 Views    PRNewswire    2019-07-18 20:11

PR Newswire

WESTBROOK, Maine, July 15, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2019 second quarter financial results for Thursday, August 1, 2019 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

Individuals can access a live webcast of the conference

0 Views    PRNewswire    2019-07-15 20:01

Jay Mazelsky, Executive Vice President, Companion Animal Group, Appointed Interim President and Chief Executive Officer

PR Newswire

WESTBROOK, Maine, July 1, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced that Chairman, President and Chief Executive Officer, Jonathan Ayers, is on a medical leave of absence following a serious bicycling accident that occurred on June 27, 2019.

0 Views    PRNewswire    2019-07-01 16:12
By Portfolio Manager Neal Rosenberg: How the 'humanization' of pets has created a booming industry

Key Points

  1. The pet industry is experiencing significant and sustainable growth
  2. Pet owners increasingly view pets as members of their family and are willing to spend accordingly; demographics suggest this will continue
  3. The animal health industry is structurally more attractive than the human health industry due to superior growth, less regulation, less costly R&D projects, and lack of third party payers
  4. We believe IDEXX (diagnostics), Dechra (veterinary pharmaceuticals), and Covetrus (veterinary technology) are excellent investment opportunities in the animal health space

According to the American Pet Products Association, Americans are spending more on pets than ever before: $73

143 Views    Holly LaFon    2019-05-21 18:55

PR Newswire

WESTBROOK, Maine, May 20, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in two upcoming conferences:

  • Wednesday, May 29, 12:30 pm EDTBrian McKeon, Executive Vice President and Chief Financial Officer, and Jay Mazelsky, Executive Vice President, Companion Animal Group, will present at the Stifel Dental and Veterinary Conference, New York,
0 Views    PRNewswire    2019-05-20 20:00
Guru stock highlight

Shares of veterinary diagnostics leader IDEXX Laboratories, Inc. (NASDAQ:IDXX) increased after the company reported robust financial results. In the core companion animal business, competitive trends are outstanding, highlighted by instrument installed base growth of 21%, domestic lab growth more than twice that of competitor VCA, and improving sales productivity. We think new proprietary innovations and field sales force expansion should be meaningful contributors to growth. Margins are moving significantly higher, and we believe they can approach 30% over the next several years.



From [url=http://www.gurufocus.com/StockBuy.php?GuruName=Ron+Baron]Ron Baron[/url] ([url=http://www.gurufocus.com/StockBuy.php?GuruName=Ron+Baron]Trades[/url], [url=http://www.gurufocus.com/holdings.php?GuruName=Ron+Baron]Portfolio[/url])'s Baron

51 Views    Holly LaFon    2019-04-29 19:41
Discussion of markets and holdings, including Tesla

After a challenging 2018, equity markets in the U.S. and abroad rebounded strongly in the first quarter of 2019. Baron Partners Fund (the “Fund”) increased in value 16.80% (Institutional Shares) per share during the first three months of 2019. Despite what were exceptional results for such a short period, Baron Partners Fund’s performance trailed that of its primary benchmark, the Russell Midcap Growth Index (“RMCG”). The RMCG gained 19.62%. Morningstar’s US Fund Mid-Cap Growth Category Average (“Morningstar Category Average”), reflecting very strong quarterly performance of mutual funds that invest in mid-sized growth companies, increased in value 18.19%. The S&P 500

472 Views    Holly LaFon    2019-04-29 19:16
Dallas-based vehicle auctioneer tops list of stalwarts in terms of operating margin

According to the All-in-One Screener, five Peter Lynch stalwarts with strong profit margins are Copart Inc. (CPRT), Intel Corp. (INTC), Edwards Lifesciences Corp. (EW), Masimo Corp. (MASI) and IDEXX Laboratories Inc. (IDXX).

Starting point: Peter Lynch Stalwarts screen

According to Investopedia, Lynch defined a stalwart as “a large, well-established company that still offers long-term growth potential.” The investor sought companies with a strong balance sheet, little or no debt, solid cash flow and earnings growth between 10% and 12%.

GuruFocus launched a new version of the All-in-One Screener

774 Views    James Li    2019-04-26 20:47

PR Newswire

WESTBROOK, Maine, April 23, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced that its Chairman and Chief Executive Officer, Jonathan Ayers, and his wife, Helaine, have established a foundation that will support conservation of the estimated 40 species of felids in the wild. The Ayers Wild Cat Conservation Trust is endowed by a gift of IDEXX stock from the Ayers family.

0 Views    PRNewswire    2019-04-23 12:02

NEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of IDEXX Laboratories, Inc. (IDXX), Aegion Corporation (AEGN), NetScout Systems, Inc. (NTCT), Castlight Health, inc. (:CSLT), Leap Therapeutics, Inc. (LPTX), and Speedway Motorsports, Inc. (:TRK), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links

0 Views    Marketwired    2019-04-12 12:01

PR Newswire

WESTBROOK, Maine, April 2, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2019 first quarter financial results for Wednesday, May 1, 2019 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

Individuals can access a live webcast of the

0 Views    PRNewswire    2019-04-02 16:03

PR Newswire

WESTBROOK, Maine, March 4, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced that Sharon Underberg has been appointed the Company's Corporate Vice President, General Counsel, and Corporate Secretary, effective March 1, 2019. In this role, Ms. Underberg leads IDEXX's global legal and compliance teams, and the office of the Corporate Secretary. She succeeds Jacqueline Studer,

0 Views    PRNewswire    2019-03-04 17:17

PR Newswire

WESTBROOK, Maine, Feb. 11, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in two upcoming conferences:

  • Monday, February 25, 10:55 am ESTBrian McKeon, Executive Vice President and Chief Financial Officer, and Jay Mazelsky, Executive Vice President, Companion Animal Group, will present at the Bank of America Merrill Lynch Animal Health Summit,
0 Views    PRNewswire    2019-02-11 21:02
Guru stock highlight

Shares of veterinary diagnostics leader IDEXX Laboratories, Inc. (NASDAQ:IDXX) detracted from performance. While financial results were strong, unfavorable weather in Europe and depressed global milk prices temporarily reduced reported growth. We estimate that just 1% to 2% of IDEXX’s profit is exposed to milk prices, and we believe that weather trends in Europe have normalized. We believe that competitive trends are outstanding in IDEXX’s core companion animal business, highlighted by instrument installed base growth of 20%, domestic lab growth more than twice that of its main competitor, and improving sales productivity. We expect new proprietary innovations and ongoing sales

59 Views    Holly LaFon    2019-01-24 20:39

NEW YORK, Jan. 24, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of First Data Corporation (:FDC), IDEXX Laboratories, Inc. (IDXX), CMS Energy Corporation (:CMS), Worthington Industries, Inc. (:WOR), Triumph Group, Inc. (:TGI), and Cara Therapeutics, Inc. (CARA), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the

0 Views    Marketwired    2019-01-24 17:01

New in-house diagnostic enables real-time and accurate prediction of timing for canine breeding

PR Newswire

WESTBROOK, Maine, Jan. 21, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced that it is introducing a new canine progesterone test for Catalyst Dx® and Catalyst One® chemistry analyzers. This much-anticipated in-house diagnostic will help veterinarians determine when a dog is ready to breed by providing a reliable,

1 Views    PRNewswire    2019-01-21 13:02

World's largest veterinary image library powers Neural Network 4.0 advancements

PR Newswire

WESTBROOK, Maine, Jan. 21, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced an update to its SediVue Dx® Urine Sediment Analyzer with its Neural Network 4.0 software release, expanding the analyzer's diagnostic capabilties. This update will be implemented across all SediVue Dx analyzer customers by the end of March, and reflects IDEXX's

1 Views    PRNewswire    2019-01-21 13:02

PR Newswire

WESTBROOK, Maine, Jan. 9, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2018 fourth quarter and full-year financial results for Friday, February 1, 2019 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

Individuals can access a live webcast of the conference

0 Views    PRNewswire    2019-01-10 01:02
PM Lauren Romeo discusses finding opportunities in the recent downturn and what she likes about four current holdings

What is your take on the recent market downturn?

Downturns are never pleasant in the short run. However, at Royce we always try to put cash to work when share prices are falling to create potentially rewarding long-term opportunities.

The kind of high-quality characteristics that we seek in Premier—companies with high returns on invested capital and sustainable competitive advantages—are usually trading more closely to their full valuation. It can take a long time for what we think are high-quality small-caps to enter a favorable valuation range.

So far in the fourth quarter, we’ve added four new names to Premier’s

66 Views    Holly LaFon    2018-12-11 20:44

NEW YORK, Nov. 12, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of IDEXX Laboratories, Inc. (IDXX), Editas Medicine, Inc. (EDIT), Arconic Inc. (:ARNC), Cardtronics PLC (CATM), Cloudera, Inc. (:CLDR), and BMC Stock Holdings, Inc. (BMCH), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

0 Views    Marketwired    2018-11-12 17:02

Headlines Total 257
  • 1
  • 2
  • 3

2019-07-17 $284.73 (0.38%)
8:34pm
2019-06-27 $272.05 (0.8%)
10:40am
2019-06-26 $269.89 (-0.52%)
7:51am
2019-06-24 $275.01 (0.39%)
12:47pm
2019-06-21 $273.93 (0.38%)
9:58am
8:37am
2019-06-14 $267.74 (0.22%)
6:24am
2019-06-07 $264.92 (2.02%)
6:52am
2019-05-31 $249.77 (0.03%)
8:31am
2019-05-29 $247.45 (0.24%)
7:32am
2019-05-07 $245.45 (-2.55%)
12:39pm
2019-05-06 $251.88 (0.56%)
5:12am
2019-05-02 $242.34 (3.54%)
8:27pm
1:28am
2019-05-01 $234.06 (0.89%)
4:19pm
3:43pm
12:16pm
10:39am
2019-04-30 $232 (0.57%)
9:04am
2019-04-29 $230.68 (-0.77%)
2:41pm
2019-04-24 $224.58 (0.06%)
9:33am
2019-03-28 $220.56 (0.79%)
10:02am
2019-03-27 $218.84 (-0.53%)
6:59am
2019-03-20 $219.27 (0.44%)
10:48am
2019-03-19 $218.3 (1.19%)
9:56am
8:35am
2019-03-18 $215.74 (-0.22%)
10:17am
2019-03-15 $216.21 (2.53%)
2:26pm
2019-03-14 $210.87 (0.47%)
2:32pm
2019-03-13 $209.89 (1.9%)
11:41am
8:58am
2019-03-12 $205.97 (0.61%)
10:27am
2019-03-08 $201.74 (-1.05%)
8:10am
2019-03-07 $203.89 (-1.89%)
7:33am
2019-03-05 $210.8 (-1.22%)
8:50am
2019-02-13 $210.39 (0.42%)
9:00am
2019-02-12 $209.5 (1.38%)
7:39am
2019-02-07 $206.81 (-0.97%)
3:43pm
2019-02-06 $208.83 (0.41%)
8:11pm
2019-02-01 $205.38 (-3.48%)
1:19pm
12:45pm
6:50am
2019-01-31 $212.78 (2.46%)
9:54am
2019-01-29 $204.29 (-0.69%)
8:30pm
2019-01-28 $205.7 (-1.51%)
8:48am
2019-01-25 $208.85 (1.3%)
9:30am
2019-01-24 $206.16 (2.24%)
2:39pm
1:35pm
2019-01-14 $189.79 (-1.62%)
9:15pm
2018-12-01
8:31am
2018-11-16 $201.37 (0.4%)
12:34pm
2018-11-12 $198.82 (-4.03%)
6:18pm
11:02am
2018-11-09 $207.17 (-1.19%)
6:46am
2018-11-08 $209.67 (-0.06%)
8:08pm
2018-11-02 $204.91 (-0.07%)
1:44pm
2018-11-01 $205.06 (-3.33%)
3:45pm
9:37am
2018-10-25 $210.78 (1.85%)
11:27am
9:34am
2018-10-23 $218.12 (-0.76%)
9:10am
2018-10-17 $228.49 (1.2%)
7:36am
2018-10-12 $222.42 (3.88%)
8:42am
7:41am
2018-09-28 $249.66 (0.39%)
1:06pm
2018-09-26 $244.39 (-0.59%)
10:30am
2018-09-25 $245.84 (1.29%)
7:40am
2018-09-18 $245.22 (0.94%)
7:07am
2018-09-17 $242.94 (-2.02%)
8:11pm
2018-09-13 $249.29 (1.48%)
8:23am
2018-09-10 $246.11 (1.47%)
7:12am
2018-09-01
12:05am
2018-08-30 $253.48 (-0.39%)
7:44am
2018-08-28 $251.7 (0.14%)
9:40am
2018-08-23 $245.97 (0.03%)
7:38am
2018-08-22 $245.89 (1.39%)
2:34am
2018-08-21 $242.52 (0.02%)
11:51am
2018-08-16 $243.26 (0.7%)
1:53pm
7:39am
6:42am
2018-08-09 $244.63 (-0.65%)
7:41am
2018-08-08 $246.22 (0.29%)
7:02pm
1:32pm
2018-08-07 $245.52 (1.07%)
8:35am
2018-08-03 $242.64 (0.76%)
3:15pm
2018-08-01 $236.15 (-3.58%)
2:50pm
12:53pm
7:33am
7:16am
7:12am
2018-07-31 $244.93 (3.02%)
8:01pm
2018-07-24 $248.07 (-0.19%)
6:47pm
2018-07-23 $248.55 (0.17%)
10:22am
2018-07-13 $238.15 (0.29%)
6:56am
2018-07-10 $234.1 (2%)
10:10am
2018-07-05 $221.84 (1.38%)
2:41pm
2018-06-26 $217.34 (-0.07%)
8:37am
2018-06-25 $217.49 (-2.43%)
10:43am
8:30am
2018-06-20 $224.98 (-0.18%)
7:24am
Total 257
  • 1
  • 2
  • 3